Risk factors for imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units in south China

被引：12
|
作者：
Rao, Y. B. [1 ,2 ]
Ren, Z. X. [1 ,2 ]
Zhong, J. J. [1 ]
Zhong, X. M. [1 ,2 ]
Cao, B. [3 ]
Chen, D. M. [4 ]
Pan, X. N. [5 ]
Jia, Y. P. [6 ]
Gao, P. M. [7 ]
Yang, B. Y. [8 ]
Zhong, Q. [9 ]
Yang, J. [1 ]
机构：
[1] Guangdong Women & Children Hosp, Dept Neonatol, Guangzhou, Guangdong, Peoples R China
[2] Guang Zhou Med Univ, Guangzhou, Guangdong, Peoples R China
[3] Women & Childrens Hosp Hunan Prov, Dept Neonatol, Changsha, Hunan, Peoples R China
[4] Women & Childrens Hosp Quanzhou, Dept Neonatol, Quanzhou, Fujian, Peoples R China
[5] Women & Childrens Hosp Guangxi Zhuang Autonomous, Dept Neonatol, Nanning, Guangxi, Peoples R China
[6] Womens & Childrens Hosp, Dept Neonatol, Haikou, Hainan, Peoples R China
[7] Women & Childrens Hosp Foshan, Dept Neonatol, Foshan, Guangdong, Peoples R China
[8] Women & Childrens Hosp Zhongshan, Dept Neonatol, Zhongshan, Guangdong, Peoples R China
[9] Women & Childrens Hosp Shenzhen, Dept Neonatol, Shenzhen, Guangdong, Peoples R China
来源：
JOURNAL OF HOSPITAL INFECTION | 2018年 / 98卷 / 03期
关键词：
Neonate; Pseudomonas aeruginosa; Imipenem; Hospital-acquired infection; NOSOCOMIAL INFECTION;
D O I：
10.1016/j.jhin.2017.12.016
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
This multi-centre retrospective study was designed to investigate the risk factors for infection with imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units (NICUs) in south China. All patients with confirmed P. aeruginosa infection from eight NICUs in south China were divided into two groups: imipenem-susceptible P. aeruginosa and imipenem-resistant P. aeruginosa. Data were analysed using Chi-squared test and logistic regression. In total, 188 medical records were reviewed. On multi-variate logistic analysis, the only independent risk factor was imipenem treatment within two weeks of isolation of P. aeruginosa (odds ratio 6.409, 95% confidence interval 1.926-21.333). (C) 2017 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
引用
收藏
页码：305 / 308
页数：4
相关论文
共 50 条
  • [11] Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections
    Suarez, Cristina
    Pena, Carmen
    Tubau, Fe
    Gavalda, Laura
    Manzur, Adriana
    Dominguez, M. Angeles
    Pujol, Miquel
    Gudiol, Francisco
    Ariza, Javier
    JOURNAL OF INFECTION, 2009, 58 (04) : 285 - 290
  • [12] Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital
    Sasaki, M
    Hiyama, E
    Takesue, Y
    Kodaira, M
    Sueda, T
    Yokoyama, T
    JOURNAL OF HOSPITAL INFECTION, 2004, 56 (02) : 111 - 118
  • [13] Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin
    Mikura, S.
    Wada, H.
    Okazaki, M.
    Nakamura, M.
    Honda, K.
    Yasutake, T.
    Higaki, M.
    Ishii, H.
    Watanabe, T.
    Tsunoda, T.
    Goto, H.
    JOURNAL OF HOSPITAL INFECTION, 2011, 79 (03) : 267 - 268
  • [14] Antimicrobial Effects of β-Lactams on Imipenem-Resistant Ceftazidime-Susceptible Pseudomonas aeruginosa
    Wi, Yu Mi
    Choi, Ji-Young
    Lee, Ji-Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Song, Jae-Hoon
    Ko, Kwan Soo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (06)
  • [15] Recombinase-aided amplification assay for rapid detection of imipenem-resistant Pseudomonas aeruginosa and rifampin-resistant Pseudomonas aeruginosa
    Zhou, Yao
    Shi, Ruiqing
    Mu, Liang
    Tian, Linlin
    Zhou, Mengshan
    Lyu, Wenhan
    Chen, Yaodong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [16] Characterization of imipenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates in a Moroccan hospital
    Benaissa, Elmostafa
    Abassour, Tilila
    Belouad, Elmehdi
    Maleb, Adil
    Elouennass, Mostafa
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2022, 69 (02) : 118 - 126
  • [17] Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases
    El-Domany, Ramadan Ahmed
    Emara, Mohamed
    El-Magd, Mohammed A.
    Moustafa, Walaa H.
    Abdeltwab, Nesma M.
    MICROBIAL DRUG RESISTANCE, 2017, 23 (06) : 682 - 686
  • [18] The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study
    Carmeli, Yehuda
    Lidji, Shiri Klarfeld
    Shabtai, Esther
    Navon-Venezia, Shiri
    Schwaber, Mitchell J.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (03) : 367 - 372
  • [19] In vitro Effects of Various Antimicrobials Alone and in Combinations against Imipenem-Resistant Pseudomonas aeruginosa
    Tunyapanit, Wanutsanun
    Pruekprasert, Pornpimol
    Laoprasopwattana, Kamolwish
    Chelae, Sureerat
    SAINS MALAYSIANA, 2019, 48 (05): : 1065 - 1073
  • [20] Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections
    Baran, Guelseren
    Erbay, Ayse
    Bodur, Huerrem
    Onguru, Pinar
    Akinci, Esraguel
    Balaban, Neriman
    Cevik, Mustafa A.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (01) : 16 - 21
12345